N-Myristoyl Lysine

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: N-Myristoyl Lysine
• 英文别名: 6-amino-2-(tetradecanoylamino)hexanoic acid
• 化学式: C₂₀H₄₀N₂O₃
• 分子量: 356.5
• InChiKey: DVHIYVOBSKWPJD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  25
• 可旋转键数：
  18
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.9
• 拓扑面积：
  92.4
• 氢给体数：
  3
• 氢受体数：
  4

文献信息

• Cosmetic powder
  申请人：Sagawa Koichiro

  公开号：US20060233728A1

  公开（公告）日：2006-10-19

  Cosmetic powders which contain an N-mono long chain acyl basic amino acid and a particular α-aminolactam derivative are superior in spreadability on the skin and affinity to the skin upon application, and the lightness and moisture of the skin after application, as well as safety.

  含有N-单长链酰基基础氨基酸和特定的α-氨基内酰胺衍生物的化妆粉末在涂抹时对皮肤的延展性和亲和力、涂抹后皮肤的轻盈和湿润度以及安全性方面表现优异。
• Surface modification using N-acyl lysines
  申请人：AJINOMOTO CO., INC.

  公开号：EP0139481A2

  公开（公告）日：1985-05-02

  There is disclosed a formulation comprising a base component in combination with one or more organic component chosen from N-mono- and N,N-di-acylated basic amino acids, wherein the acyl group in the N-mono-acylated basic amino acid is an aliphatic acyl group having from 8 to 22 carbon atoms, and each of the acyl groups, which may be the same or different, in the N,N-di-acylated basic amino acid is an aliphatic acyl group having from 1 to 22 carbon atoms with the proviso that the two aliphatic acyl groups together have from 9 to 44 carbon atoms. The formulation is useful in novel cosmetics and as a novel surface-modified inorganic filler.

  本发明公开了一种制剂，该制剂由基质成分与一种或多种选自 N-单-和 N,N-二-酰化碱性氨基酸的有机成分组合而成，其中 N-单-酰化碱性氨基酸中的酰基是具有 8 至 22 个碳原子的脂肪族酰基、N,N-二乙酰化碱性氨基酸中的每个酰基（可以相同或不同）都是具有 1 至 22 个碳原子的脂肪族酰基，但这两个脂肪族酰基加在一起具有 9 至 44 个碳原子。 该配方可用于新型化妆品和新型表面改性无机填料。
• HYDROPHOBIC ALGINIC ACID PARTICLE GROUP AND METHOD FOR PRODUCING SAME
  申请人：Nisshinbo Holdings Inc.

  公开号：EP3922666A1

  公开（公告）日：2021-12-15

  The present invention provides a hydrophobic alginic acid particle group which is obtained by subjecting a polyvalent metal alginate to a hydrophobization treatment, and which is configured such that the water absorption per 100 g of the particles is lower than the oil absorption per 100 g of the particles.

  本发明提供了一种疏水性海藻酸粒子群，它是通过对多价金属海藻酸盐进行疏水处理而获得的，其配置使得每 100 克粒子的吸水率低于每 100 克粒子的吸油量。
• Molecular vaccines for infectious disease
  申请人：Schøller Jørgen

  公开号：US10369204B2

  公开（公告）日：2019-08-06

  The present invention relates to methods for construction of pharmamers i.e. vaccine components characterized by their multimerization domain and the attached biologically active molecules, and their use in preparation of vaccines that contains the pharmamers alone or in combination with other molecules. The individual molecules of the construct can be bound to each other or the multimerization domain(s) by covalent or non-covalent bonds, directly or via linkers. The invention further relates to the use of such preparations in vaccine settings aimed to function as preventive/prophylactic or therapeutic vaccines in humans and animals.

  本发明涉及构建药剂的方法，即以其多聚化结构域和所附生物活性分子为特征的疫苗成分，以及将其用于制备单独含有药剂或与其他分子结合的疫苗。构建体的各个分子可以通过共价键或非共价键，直接或通过连接体相互结合或与多聚化结构域结合。本发明进一步涉及此类制剂在疫苗中的使用，旨在作为人类和动物的预防/预防性或治疗性疫苗。
• MHC multimers in tuberculosis diagnostics, vaccine and therapeutics
  申请人：Schøller Jørgen

  公开号：US10611818B2

  公开（公告）日：2020-04-07

  The present invention relates to MHC-peptide complexes and uses thereof in the diagnosis of, treatment of or vaccination against a disease in an individual. More specifically the invention discloses MHC complexes comprising Mycobacterium tuberculosis antigenic peptides and uses there of.

  本发明涉及 MHC 肽复合物及其在个体疾病诊断、治疗或疫苗接种中的用途。更具体地说，本发明公开了包含结核分枝杆菌抗原肽的 MHC 复合物及其用途。